A kind of human primary cell culture medium and its application

A culture medium and basal medium technology, applied in animal cells, tissue culture, vertebrate cells, etc., can solve problems such as troublesome operation steps, insufficient practicability, and accelerated differentiation and aging of primary cells and progenitor cells, achieving The effect of high amplification efficiency and long culture time

Active Publication Date: 2019-06-21
GUANGZHOU INST OF BIOMEDICINE & HEALTH CHINESE ACAD OF SCI
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] An article titled "Long–term culture of primary human lymphoblasticleukemia cells in the absence of serum or hematopoietic growth factors" in 2009 mentioned the in vitro culture medium of primary lymphocytic leukemia cells, which was supplemented with the cytokine IL -3. Serum-free IMDM medium of IL-7 and SCF; although this medium does not contain serum, however, the inventors of the present invention used this medium to carry out repeated experiments and found that the culture effect described in the article could not be achieved , that is, its stability needs to be investigated;
[0010] It should be noted that although serum is necessary for the survival and culture of traditional cells in vitro, when human primary cells are cultured in vitro, serum can accelerate the differentiation and aging of primary cells, especially hematopoietic stem cells and progenitor cells; Moreover, as far as the serum itself is concerned, even if it is the serum of the same brand, there may be obvious differences between different batches of serum, which makes the culture effect also have obvious differences, so the use of serum-containing medium has unclear medium components. The problem is that the practicability is relatively insufficient
[0011] However, co-cultivation with stromal cells is not only cumbersome, but also the growth rate of stromal cells (especially immortalized cell lines) far exceeds that of primary cells during the co-cultivation process, which competes with primary cells for nutrients in the medium. , thereby affecting the growth of primary cells; in addition, stromal cells activate the survival and expansion of primary cells in vitro through protein secretion or receptor binding, but these activation factors are uncontrollable with the cell state, differentiation, aging, and passage times of stromal cells. Factors are related, resulting in obvious differences in the culture effect of primary cells cultured by the stromal cell co-culture method, which is difficult to repeat and is not conducive to popularization and application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of human primary cell culture medium and its application
  • A kind of human primary cell culture medium and its application
  • A kind of human primary cell culture medium and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] Example 1 evaluates the success rate of culturing human primary B-ALL cells in vitro using the culture medium of the present invention

[0047] Human primary B-ALL cells were isolated and obtained by density centrifugation, and the specific steps were as follows:

[0048] 1) Mix the bone marrow or peripheral blood samples of B-ALL patients with normal saline in equal proportions;

[0049] 2) In a new 15mL centrifuge tube, add one-half of the diluted blood volume in lymphatic separation fluid (Lymphoprep, StemCell Technologies);

[0050] 3) Slowly superimpose the diluted blood on the layered liquid surface along the wall of the centrifuge tube, keeping the liquid surface clear;

[0051] 4) Gently put the bone marrow sample mixture centrifuge tube into the centrifuge, and centrifuge at 800g / min for 20min;

[0052] 5) Gently take out the centrifuge tube, layer the bone marrow sample mixture, use a Pasteur pipette to carefully absorb the cells in the middle cloud layer ...

Embodiment 2

[0059] Example 2 evaluates the cell viability of culturing human primary B-ALL cells in vitro using the culture medium of the present invention

[0060] Using the human primary B-ALL cell sample prepared in Example 1, using the control medium containing serum but not containing cytokine combination as a control, evaluate the cell survival of human primary B-ALL cells cultured in vitro using the medium of the present invention Rate. The composition of the control medium is: IMDM+10%FBS+1% / P / S+5mM glutamate; the composition of the medium of the present invention is: IMDM+1% / P / S+5mM glutamate+cytokines combination , the composition and content of the cytokine combination are shown in the following table:

[0061]

[0062]

[0063] Specifically, a certain number of primary human B-ALL cells were inoculated on a culture plate, and the ratio of viable cells to the total number of cells was detected on the 3rd day and 7th day, respectively.

[0064] results like 2 and ima...

Embodiment 3

[0065] Example 3 Use the culture medium of the present invention to culture the cell growth curve of human primary B-ALL cells in vitro

[0066] Using the human primary B-ALL cell sample prepared in Example 1, using the control medium containing serum but not containing cytokine combination as a control, evaluate the cell growth of human primary B-ALL cells cultured in vitro using the medium of the present invention situation. The composition of the control medium is: IMDM+10%FBS+1% / P / S+5mM glutamate; the composition of the medium of the present invention is: IMDM+1% / P / S+5mM glutamate+cytokines combination , the composition and content of the cytokine combination are shown in the following table:

[0067] Element concentration BSA 5mg / ml Transferrin 5ug / ml insulin 5ug / ml humanFLT3L 50ng / ml hIGF1 50ng / ml hIL-7 20ng / ml hIL-6 20ng / ml

[0068] Specifically, the 5×10 5 The primary B-ALL cells were inoculated in a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Provided are a primary cell culture medium, use thereof for culturing a human primary cell in vitro, and method for utilizing the culture medium to culture a human primary B-cell acute lymphoblastic leukemia (B-ALL) cell in vitro. The primary cell culture medium comprises a base culture medium and cell factors: human FLT3L, human IGFl, human IL-7 and human IL-6, and is serum-free.

Description

technical field [0001] The present invention relates to the technical field of cell culture, in particular to a primary cell culture medium, the use of the medium for culturing human primary cells in vitro, and the use of the culture medium for culturing primary human acute lymphoblastic leukemia (B- ALL) cell method. Background technique [0002] B-cell acute lymphoblastic leukemia (B-ALL, B-cell acute lymphoblastic leukemia), also known as precursor B-cell (pre B-cell) acute lymphoblastic leukemia, is a malignant tumor derived from B-cell progenitor cells. B-ALL is mainly a high-incidence cancer in children, and its incidence rate decreases in adults. Prognosis is good in juvenile patients with B-ALL, and the long-term survival rate (EFS, event-free survival) can reach 90%, but it is poor prognosis and low survival rate in B-ALL adults. In addition, in adult B-ALL patients, the effect of traditional chemotherapy is poor, and the mortality rate is about 60%. Therefore, t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/09
CPCC12N5/00
Inventor 李鹏蒋治武林思妙叶未姚瑶
Owner GUANGZHOU INST OF BIOMEDICINE & HEALTH CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products